EE79 A Cost of Control Analysis of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide for Bringing Patients to Treatment Targets in China
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.333
https://www.valueinhealthjournal.com/article/S1098-3015(22)00534-4/fulltext
Title :
EE79 A Cost of Control Analysis of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide for Bringing Patients to Treatment Targets in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00534-4&doi=10.1016/j.jval.2022.04.333
First page :
Section Title :
Open access? :
No
Section Order :
10290